European Heart Journal

• NT-proBNP and High Intensity Care for Acute Heart Failure This study assessed the role of NT-proBNP in patients receiving rapid up-titration of guideline-recommended medical therapy for acute heart failure.
  European Heart Journal, September 21, 2023
• Mechanisms of SGLT2 Inhibitors and Diuretics in HF A new analysis helps clarify our understanding of how SGLT2 inhibitors reduce the risk of adverse outcome in patients with HFpEF, HFmrEF, and HFrEF.
  European Heart Journal, September 19, 2023
• Single hs-cTn Sample to Safely Rule Out NSTEMI-ACS A new study confirms that an undetectable cardiac Tn using a high sensitivity assay is a valid indicator of very low cardiac risk in patients presenting with suspected NSTEMI-ACS in the ED.
  European Heart Journal, September 14, 2023
• Migraine and CVD: What Cardiologists Should Know This state-of-the-art review outlines the basic pathophysiology of migraine and the associations between migraine and cardiovascular disease. What are future directions for research?
  European Heart Journal, August 31, 2023
• Novel Mechanisms and Therapeutic Targets in Atherosclerosis This state-of-the-art review highlights recent experimental and translational advances regarding anti-inflammatory therapeutic strategies targeting atherosclerosis.
  European Heart Journal, August 24, 2023
• Modifiable CV Risk Factors for Targeted Prevention of Dementia This review summarizes the potential cardiovascular causes of dementia. Can dementia risk prediction be optimized by combining genetics and cardiovascular risk factors?
  European Heart Journal, August 22, 2023
• Is it Time for a Biopsychosocial CVD Model? A new study confirms that social isolation and loneliness have a significant impact on CVD risk.
  European Heart Journal, August 17, 2023
• AF Ablation Remains Effective After a Year of Waiting A recent study found that AF ablation retains its effectiveness in preventing AF, even if performed after a year on antiarrhythmic drug therapy.
  European Heart Journal, August 15, 2023
• Pacing or Ablation for Vasovagal Syncope? This article presents a practical decision pathway for the management of vasovagal syncope in differing subsets of patients.
  European Heart Journal, August 10, 2023
• Should CTCA Be the Initial Diagnostic Test in Suspected Angina? In this debate, clinicians present opposing views of computed tomography coronary angiography as a first-line testing option in patients with acute or chronic chest pain without known CAD.
  European Heart Journal, August 08, 2023
• The Paradox of Coronary Artery Disease in Veteran Athletes A new study aims to elucidate the relationship between exercise dose and cardiovascular health. Why are lifelong endurance athletes more likely to exhibit elevated CAC and atherosclerotic plaque?
  European Heart Journal, August 03, 2023
• Should Lipid-lowering Therapies Be Guided By Vascular Imaging? Is imaging or a biomarker better suited to help choose the ideal lipid lowering regimen in a given individual?
  European Heart Journal, August 01, 2023
• Statins Revisited: Applications Beyond Lipid Lowering? Are we using statins to their full potential? Recent studies suggest a larger role for statins beyond their cholesterol-lowering properties.
  European Heart Journal, July 27, 2023
• Importance of Cystatin C in Estimating GFR This study examined the clinical implications of the recently implemented CKD-EPI creatinine-cystatin C equation for determining glomerular filtration rate. Might it overestimate GFR in some patients?
  European Heart Journal, July 25, 2023
• Takotsubo Syndrome and Coronary Microvascular Dysfunction A pre-clinical animal study links microvascular coronary flow regulation and mechanical stress to Takutsubo syndrome onset and treatment.
  European Heart Journal, July 20, 2023
• Targeting Regulatory RNAs at the Heart of Parkinson's Disease Might regulatory RNAs prove to be the bridge between cardiovascular disease and Parkinson's disease? Could they be a disease-modifying target for PD therapy?
  European Heart Journal, July 13, 2023
• Vitamin D in Atherosclerosis and Cardiovascular Events This state-of-the-art review aims to shed light on the complex interplay between Vitamin D and cardio-metabolic risk.
  European Heart Journal, July 11, 2023
• Residual CV Risk in the Statin Era: Cholesterol or Inflammation? Should we be targeting inflammation in patients with or at high risk for ASCVD, in addition to intensive statin therapy?
  European Heart Journal, July 06, 2023
• Digitalis in HF: Declining Use and Ongoing Outcome Trials Why has the use of digitalis in the treatment of heart failure declined so significantly in the last 25 years? Should its potential role be reappraised? Two new studies aim to assess its future.
  European Heart Journal, July 04, 2023
• Exercise Benefits in Cardiovascular Diseases This paper reviews the benefits and mechanisms of physical activity in primary and secondary CVD prevention, highlighting current evidence for safe implementation of exercise in patients with CVD.
  European Heart Journal, June 22, 2023